Vikas Gupta
@Vikas_Gupta_1
Followers
2K
Following
2K
Media
43
Statuses
2K
Leukemia Multidisciplinary Clinical Lead, Director, MPN Program, Princess Margaret Cancer Center; Founder, Canadian MPN Group; tweets are personal
Toronto
Joined July 2014
RT @BCD_AACR: Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Dif….
0
4
0
RT @PMResearch_UHN: A real-world study validates the LSC17 score's ability to predict AML patient outcomes and identify high-risk patients….
0
3
0
RT @nihardesai89: IDAC vs HiDAC as post-induction consolidation in AML.
evidence.nejm.org
We conducted a randomized controlled trial to compare intermediate doses (IDAC) with high doses of cytarabine (HDAC) as postinduction therapy in patients 18 to 60 years of age with newly diagnosed ...
0
15
0
RT @AML_Hub: 📝 A new study published in @BMTjournal indicates that common barriers to HSCT in patients with TP53m AML include infection, co….
0
4
0
RT @AML_Hub: CONGRESS | #EHA2025 | PRESENTATION.MarĂa Queralt Salas @QueraltSalas @hospitalclinic presents results from a prospective multi….
0
10
0
RT @MPN_Hub: CONGRESS | #EHA2025 | PRESENTATION.Beth Psaila, @beth_psaila, @MRC_WIMM, gives a talk about a mutCALR×CD3 antibody (INCA035784….
0
4
0
RT @MPN_Hub: CONGRESS | #EHA2025 | PRESENTATION.John Mascarenhas, @IcahnMountSinai shares preliminary results from the dose-escalation coho….
0
11
0
RT @MPN_Hub: CONGRESS | #EHA25 | PRESENTATION.Vikas Gupta @Vikas_Gupta_1 @pmcancercentre discusses management of accelerated and blast phas….
0
6
0
RT @doctorpemm: 👉👉👉Just in time for #EHA2025 #EHA25 | Treatment patterns and blood count control in 10,112 patients with polycythemia vera:….
tandfonline.com
Elevated blood counts in polycythemia vera (PV) are associated with increased thrombotic risk, which contributes to morbidity and mortality.This retrospective study describes treatment patterns and...
0
7
0
RT @bose_prithviraj: Sustained benefits of rux+pelabresib over rux+placebo in 1L MF at week 72 in the phase 3 MANIFEST2 study. Especially g….
0
6
0
RT @doctorpemm: #EHA2025 #EHA25 | Just arriving at @EHA_Hematology meeting - already starting with excellent, highly productive, intense di….
0
6
0
0
50
0
RT @mpdrc: Amazing day at #ASCO25 plenary session! First an #MPN abstract in the plenary! Second, amazing job by @KuykendallMd for presenti….
0
13
0
RT @mpdrc: Joining the incomparable #ShannonElf @TheElfLab at the 17th #EuroNetMPN&MPNr meeting in #StGallen @Vikas_Gupta_1 @FlorianHeidel….
0
4
0
RT @MostafaFaisal14: Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor S….
onlinelibrary.wiley.com
This study of 308 myelofibrosis patients shows that in recent years (2013–2019), alternative donors (mismatched unrelated donors and cord blood) achieved survival rates comparable to HLA-matched...
0
2
0
RT @PMResearch_UHN: Read more on the AML differentiation patterns here: .
linkedin.com
Understanding cancer cell development in AML🩸 A study led by our researchers Drs. Andy Zeng and John Dick revealed 12 distinct differentiation states of cancer cells that can emerge in acute myeloid...
0
1
0
RT @Blood_Cancers: From JAK and BET inhibitors to mutation clearance after HSCT, our section editor @RaajitRampal highlighted recent resear….
0
4
0
RT @TalhaBadarMD: #weekend_review.#medtwitter #hemonctrainees. #1 Genomic landscape and outcome of #TP53 mutated #MPN #mpnsm .1) Impact of….
0
7
0